诺诚健华(688428)披露证券变动月报表,4月3日股价下跌1.9%

中金财经
Apr 03

  h2,h3,h4{padding: 10px 0;font-size: 16px;line-height: 30px;color:#262626;font-weight: 600;}h2{border-bottom: 1px solid #d8dee4; padding-bottom: 0.3em}.article_content ul{padding-left:22px;}截至2026年4月3日收盘,诺诚健华(688428)报收于29.38元,较前一交易日下跌1.9%,最新总市值为518.45亿元。该股当日开盘29.51元,最高30.16元,最低28.6元,成交额达6.59亿元,换手率为8.32%。近日,诺诚健华发布港股公告《证券变动月报表》。公告显示,截至2026年3月31日,公司法定注册资本无变动,已发行股份总数与上月底结存一致,无增减。其中,港股上市普通股已发行股份(不包括库存股)为1,493,798,235股,库存股为2,486,000股;于上交所科创板上市的人民币普通股为268,359,717股。公司确认符合香港联交所规定的公众持股量要求。此外,2023年及2024年人民币股股权激励计划项下部分限制性股票失效,但本月未因协议安排导致股份增减。最新公告列表《港股公告:证券变动月报表》为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10